Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 0 | |
Outperform | 4 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in CNY
The 2 analysts offering 12 month price targets for Henan Lingrui Pharmaceutical Co., Ltd. have a median target of 30.05, with a high estimate of 30.50 and a low estimate of 29.60. The median estimate represents a 44.40% increase from the last price of 20.81.
High | 46.6% | 30.50 |
Med | 44.4% | 30.05 |
Low | 42.2% | 29.60 |
Dividends
Div growth (TTM) | 33.33% |
---|
More ▼
Earnings history & estimates in CNY
Average growth rate | +28.92% |
More ▼
Revenue history & estimates in CNY
Average growth rate | +16.40% |
More ▼